US: BRIBF - Brii Biosciences Limited

六个月盈利: +139.04%
股息率: 0.00%

促销时间表 Brii Biosciences Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Brii Biosciences Limited

Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV.

更多详情
It develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cny
Сайт https://www.briibio.com
Цена ао 0.302
每日价格变化: 0% (0.3)
每周价格变化: -0.6623% (0.302)
每月价格变化: +122.88% (0.1346)
3个月内价格变化: +139.04% (0.1255)
六个月内的价格变化: +139.04% (0.1255)
每年价格变化: +30.49% (0.2299)
3年内价格变化: -86.24% (2.18)
年初以来价格变化: +139.04% (0.1255)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
全部的: 2.5

效率

姓名 意义 年级
ROA, % 0 0
ROE, % 0 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA 0 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -78.73 0
盈利能力 Ebitda, % -67.51 0
盈利能力 EPS, % -95.34 0
全部的: 2
更多详情

导师 职称 支付 出生年份
Dr. Zhi Hong Ph.D. Co-founder, Executive Chairman of the Board & CEO 1964 (61 年)
Dr. Ankang Li C.F.A., J.D., Ph.D. Chief Financial & Strategy Officer, Company Secretary and Executive Director 1979 (46 年)
Dr. Eleanor de Groot Ph.D. Chief Technology Officer 1969 (56 年)
Dr. Brian Alvin Johns Ph.D. Chief Scientific Officer
Sarah Qiu Associate Director of Investor Relations
Ms. Karen Del Barrio Neuendorff Chief People Officer & Head of Human Resources 1976 (49 年)
Mr. Coy Stout Head of Patient Advocacy 1972 (53 年)
Dr. Lianhong Xu Ph.D. Head of Discovery 1967 (58 年)
Dr. Qing Zhu Ph.D. Head of China Research & Development 1968 (57 年)
Dr. David Margolis M.D., M.P.H. Chief Medical Officer 1975 (50 年)

地址: China, Beijing, Building 7 International Science Park - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.briibio.com